MXPA97009801A - Composiciones liofilizadas que contienen tpo estables. - Google Patents

Composiciones liofilizadas que contienen tpo estables.

Info

Publication number
MXPA97009801A
MXPA97009801A MXPA97009801A MX9709801A MXPA97009801A MX PA97009801 A MXPA97009801 A MX PA97009801A MX PA97009801 A MXPA97009801 A MX PA97009801A MX 9709801 A MX9709801 A MX 9709801A MX PA97009801 A MXPA97009801 A MX PA97009801A
Authority
MX
Mexico
Prior art keywords
composition containing
dried composition
stable freeze
containing tpo
tpo
Prior art date
Application number
MXPA97009801A
Other languages
English (en)
Spanish (es)
Inventor
Nomura Hideaki
Original Assignee
Kirin Brewery
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery filed Critical Kirin Brewery
Publication of MXPA97009801A publication Critical patent/MXPA97009801A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/196—Thrombopoietin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA97009801A 1995-06-08 1996-06-07 Composiciones liofilizadas que contienen tpo estables. MXPA97009801A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14207595 1995-06-08
PCT/JP1996/001561 WO1996041642A1 (en) 1995-06-08 1996-06-07 Stable freeze-dried composition containing tpo

Publications (1)

Publication Number Publication Date
MXPA97009801A true MXPA97009801A (es) 2003-10-30

Family

ID=15306858

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA97009801A MXPA97009801A (es) 1995-06-08 1996-06-07 Composiciones liofilizadas que contienen tpo estables.

Country Status (8)

Country Link
EP (1) EP0841066A1 (en:Method)
KR (1) KR19990022398A (en:Method)
CN (1) CN1192691A (en:Method)
AU (1) AU5911796A (en:Method)
CA (1) CA2223749A1 (en:Method)
MX (1) MXPA97009801A (en:Method)
TW (1) TW497972B (en:Method)
WO (1) WO1996041642A1 (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001501619A (ja) * 1996-10-04 2001-02-06 アムジェン インコーポレーテッド ｍｐｌリガンドを含有する医薬組成物
US20030104996A1 (en) * 2001-08-30 2003-06-05 Tiansheng Li L-methionine as a stabilizer for NESP/EPO in HSA-free formulations
DE10204792A1 (de) * 2002-02-06 2003-08-14 Merck Patent Gmbh Lyophilisierte Zubereitung enthaltend Immuncytokine
DE10333317A1 (de) * 2003-07-22 2005-02-17 Biotecon Therapeutics Gmbh Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA)
CN102552184A (zh) * 2012-02-16 2012-07-11 山东泉港药业有限公司 一种血小板生成素拟肽冻干制剂
CN111588841A (zh) * 2019-02-21 2020-08-28 中国人民解放军军事科学院军事医学研究院 一种可气溶胶化的seb类毒素疫苗干粉吸入剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
EP0466780A4 (en) * 1989-04-03 1992-08-26 Genetics Institute, Inc. Megakaryocyte growth promoting activity
ATE139700T1 (de) * 1991-02-15 1996-07-15 Takeda Chemical Industries Ltd Mit einem zellwachstumsfaktor bewirkte anregung von wachstum im knocheninneren
AU4190893A (en) * 1992-07-17 1994-01-20 Suntory Limited Megakaryocyte differentiation factor
SG47030A1 (en) * 1994-01-03 1998-03-20 Genentech Inc Thrombopoietin
AU1843595A (en) * 1994-02-14 1995-08-29 University Of Washington Methods for stimulating erythropoiesis using thrombopoietin
WO1995021919A2 (en) * 1994-02-14 1995-08-17 Kirin Brewery Company, Limited Protein having tpo activity
NZ271230A (en) * 1994-02-14 1998-03-25 Zymogenetics Inc Hematopoietic proteins, production and use
DE69503849T2 (de) * 1994-03-31 1999-04-01 Amgen Inc., Thousand Oaks, Calif. Zusammensetzungen und Verfahren zur Anregung des Wachstums und der Differenzierung von Megakaryozyten
US6790439B1 (en) * 1995-06-07 2004-09-14 Zymogenetics, Inc. Thrombopoietin compositions

Also Published As

Publication number Publication date
EP0841066A4 (en:Method) 1998-06-03
TW497972B (en) 2002-08-11
WO1996041642A1 (en) 1996-12-27
AU5911796A (en) 1997-01-09
CA2223749A1 (en) 1996-12-27
KR19990022398A (ko) 1999-03-25
CN1192691A (zh) 1998-09-09
EP0841066A1 (en) 1998-05-13

Similar Documents

Publication Publication Date Title
ZA968250B (en) Cosmetic composition.
ZA964433B (en) Cosmetic composition.
ZA966814B (en) Clear cosmetic gel composition.
PH31158A (en) Cosmetic composition.
HUP9802544A3 (en) Cable-sheathing composition
ZA965190B (en) Pharmaceutical composition.
ZA978178B (en) Composition.
ZA966148B (en) Novel formulation.
AU5183496A (en) Polymeric composition
SG52651A1 (en) Composition
PL322571A1 (en) Deodoising composition
ZA988142B (en) Cosmetic composition.
ZA975261B (en) Composition.
ZA956877B (en) Cosmetic composition.
GB9518033D0 (en) Composition
HU9600352D0 (en) Bitumenous composition
ZA968081B (en) Pharmaceutical composition.
EP0848745A4 (en) FOAMING COMPOSITION
ZA965292B (en) Enzymatic composition.
ZA963697B (en) Clear cosmetic stick composition.
AU5911796A (en) Stable freeze-dried composition containing tpo
PL327087A1 (en) Solid composition
GB9508323D0 (en) Composition
ZA97698B (en) Composition
ZA968552B (en) Cosmetic compositions.